Live Breaking News & Updates on Patrickb Mark

Stay updated with breaking news from Patrickb mark. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

EMPA-Kidney Seals SGLT2 Inhibitors as 'Foundational' for CKD

Empagliflozin s efficacy in a range of patients with chronic kidney disease in EMPA-Kidney filled evidence gaps and confirmed SGLT2 inhibitors as a key treatment regardless of diabetes status. ....

United States , United Kingdom , Natalie Staplin , Patrickb Mark , Janani Rangaswami , Naveed Sattar , American Heart Association , Boehringer Ingelheim , University Of Glasgow , Renal Studies Group At Oxford University , American Society Of Nephrology , George Washington University School Of Medicine , Novo Nordisk , Health Sciences , New England Journal , Kidney Week , George Washington University School , Oxford University Based , American Society , Diabetes Status , Renal Studies Group , Oxford University , Scientific Sessions , Improve Uptake , Chronic Renal Failure , Hronic Kidney Failure ,